http://www.aktiencheck.de aktiencheck.de aktiencheck.de Sat, 18 Apr 2026 15:55:26 +0200 2 http://www.aktiencheck.de/forum/SCICLONE_PHARMACEUTICALS_solides_Investment-886644-t399175 http://www.aktiencheck.de/forum/SCICLONE_PHARMACEUTICALS_solides_Investment-886644-t399175 4Q profit on sales, NEW YORK (AP) -- SciClone Pharmaceuticals Inc. reported a fourth-quarter profit on higher sales of the vaccine booster Zadaxin and lower costs. The company earned $2.4 million, or 5 cents per share, compared with a loss of $3.1 million, or 7 cents per share, a year earlier. Revenue rose to $18.1 million from $15.3 million. The results topped the average analyst estimate for a profit of 2 cents per share and revenue of $18 million, according to a survey by Thomson Reuters. For the full year, SciClone Pharmaceuticals earned $11.9 million, or 25 cents per share, compared with a loss of $8.3 million, or 18 cents per share, in 2008. Revenue rose to $72.4 million from $54.1 million. Looking ahead, the company expects profit between 31 cents per share and 35 cents per share on revenue between $82 million and $85 million in 2010. In after-hours trading, shares advanced 19 cents, or 5.4 percent, to $3.69, from the regular close of $3.50. http://finance.yahoo. [<a href="http://www.aktiencheck.de/forum/SCICLONE_PHARMACEUTICALS_solides_Investment-886644-t399175">mehr</a>] http://www.aktiencheck.de/forum/SciClone_o_T-886644-t207128 http://www.aktiencheck.de/forum/SciClone_o_T-886644-t207128 was meinst du denn dazu? o. T. [<a href="http://www.aktiencheck.de/forum/SciClone_o_T-886644-t207128">mehr</a>]